These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 24618609)
1. Loss of SMAD4 protein expression is associated with high tumor grade and poor prognosis in disseminated appendiceal mucinous neoplasms. Davison JM; Hartman DA; Singhi AD; Choudry HA; Ahrendt SA; Zureikat AH; Ramalingam L; Nikiforova M; Pai RK Am J Surg Pathol; 2014 May; 38(5):583-92. PubMed ID: 24618609 [TBL] [Abstract][Full Text] [Related]
2. GNAS is frequently mutated in both low-grade and high-grade disseminated appendiceal mucinous neoplasms but does not affect survival. Singhi AD; Davison JM; Choudry HA; Pingpank JF; Ahrendt SA; Holtzman MP; Zureikat AH; Zeh HJ; Ramalingam L; Mantha G; Nikiforova M; Bartlett DL; Pai RK Hum Pathol; 2014 Aug; 45(8):1737-43. PubMed ID: 24925222 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor grade. Davison JM; Choudry HA; Pingpank JF; Ahrendt SA; Holtzman MP; Zureikat AH; Zeh HJ; Ramalingam L; Zhu B; Nikiforova M; Bartlett DL; Pai RK Mod Pathol; 2014 Nov; 27(11):1521-39. PubMed ID: 24633196 [TBL] [Abstract][Full Text] [Related]
4. Whole-genome allelotyping identified distinct loss-of-heterozygosity patterns in mucinous ovarian and appendiceal carcinomas. Feltmate CM; Lee KR; Johnson M; Schorge JO; Wong KK; Hao K; Welch WR; Bell DA; Berkowitz RS; Mok SC Clin Cancer Res; 2005 Nov; 11(21):7651-7. PubMed ID: 16278384 [TBL] [Abstract][Full Text] [Related]
5. Heterogeneous mutational profile and prognosis conferred by TP53 mutations in appendiceal mucinous neoplasms. Zhu X; Salhab M; Tomaszewicz K; Meng X; Mathew C; Bathini V; Switzer B; Walter O; Cosar EF; Wang X; Lambert LA; Hutchinson LM Hum Pathol; 2019 Mar; 85():260-269. PubMed ID: 30458197 [TBL] [Abstract][Full Text] [Related]
6. Genetic alterations in goblet cell carcinoids of the vermiform appendix and comparison with gastrointestinal carcinoid tumors. Stancu M; Wu TT; Wallace C; Houlihan PS; Hamilton SR; Rashid A Mod Pathol; 2003 Dec; 16(12):1189-98. PubMed ID: 14681318 [TBL] [Abstract][Full Text] [Related]
7. Loss of chromosome 18q and DPC4 (Smad4) mutations in appendiceal adenocarcinomas. Maru D; Wu TT; Canada A; Houlihan PS; Hamilton SR; Rashid A Oncogene; 2004 Jan; 23(3):859-64. PubMed ID: 14647445 [TBL] [Abstract][Full Text] [Related]
8. Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases. Misdraji J; Yantiss RK; Graeme-Cook FM; Balis UJ; Young RH Am J Surg Pathol; 2003 Aug; 27(8):1089-103. PubMed ID: 12883241 [TBL] [Abstract][Full Text] [Related]
9. Allelic analysis of serous ovarian carcinoma reveals two putative tumor suppressor loci at 18q22-q23 distal to SMAD4, SMAD2, and DCC. Lassus H; Salovaara R; Aaltonen LA; Butzow R Am J Pathol; 2001 Jul; 159(1):35-42. PubMed ID: 11438451 [TBL] [Abstract][Full Text] [Related]
10. [Clinicopathological features and prognosis of primary appendiceal adenocarcinoma]. Liang JW; Wang Z; Zhou ZX; Zhang XM; Hu JJ; Zhao P Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):616-9. PubMed ID: 23158998 [TBL] [Abstract][Full Text] [Related]
11. SMAD4 as a prognostic marker in colorectal cancer. Alazzouzi H; Alhopuro P; Salovaara R; Sammalkorpi H; Järvinen H; Mecklin JP; Hemminki A; Schwartz S; Aaltonen LA; Arango D Clin Cancer Res; 2005 Apr; 11(7):2606-11. PubMed ID: 15814640 [TBL] [Abstract][Full Text] [Related]
12. Analysis of loss of heterozygosity for tumor-suppressor genes can accurately classify and predict the clinical behavior of mucinous tumors arising from the appendix. Maheshwari V; Tsung A; Lin Y; Zeh HJ; Finkelstein SD; Bartlett DL Ann Surg Oncol; 2006 Dec; 13(12):1610-6. PubMed ID: 17009159 [TBL] [Abstract][Full Text] [Related]
13. Chromosome 18q deletion and Smad4 protein inactivation correlate with liver metastasis: A study matched for T- and N- classification. Tanaka T; Watanabe T; Kazama Y; Tanaka J; Kanazawa T; Kazama S; Nagawa H Br J Cancer; 2006 Dec; 95(11):1562-7. PubMed ID: 17088901 [TBL] [Abstract][Full Text] [Related]
14. Defective mismatch repair in the pathogenesis of low-grade appendiceal mucinous neoplasms and adenocarcinomas. Misdraji J; Burgart LJ; Lauwers GY Mod Pathol; 2004 Dec; 17(12):1447-54. PubMed ID: 15354187 [TBL] [Abstract][Full Text] [Related]
15. Differential protein immunoexpression profiles in appendiceal mucinous neoplasms: a special reference to classification and predictive factors. Yoon SO; Kim BH; Lee HS; Kang GH; Kim WH; Kim YA; Kim JE; Chang MS Mod Pathol; 2009 Aug; 22(8):1102-12. PubMed ID: 19448592 [TBL] [Abstract][Full Text] [Related]
17. Mucinous and nonmucinous appendiceal adenocarcinomas: different clinicopathological features but similar genetic alterations. Kabbani W; Houlihan PS; Luthra R; Hamilton SR; Rashid A Mod Pathol; 2002 Jun; 15(6):599-605. PubMed ID: 12065772 [TBL] [Abstract][Full Text] [Related]
18. Molecular and clinicopathological features of appendiceal mucinous neoplasms. Yanai Y; Saito T; Hayashi T; Akazawa Y; Yatagai N; Tsuyama S; Tomita S; Hirai S; Ogura K; Matsumoto T; Wada R; Yao T Virchows Arch; 2021 Mar; 478(3):413-426. PubMed ID: 32821969 [TBL] [Abstract][Full Text] [Related]
19. Cytokeratins 7 and 20, Dpc4, and MUC5AC in the distinction of metastatic mucinous carcinomas in the ovary from primary ovarian mucinous tumors: Dpc4 assists in identifying metastatic pancreatic carcinomas. Ji H; Isacson C; Seidman JD; Kurman RJ; Ronnett BM Int J Gynecol Pathol; 2002 Oct; 21(4):391-400. PubMed ID: 12352188 [TBL] [Abstract][Full Text] [Related]
20. Appendiceal mucinous neoplasms: clinicopathologic study of 116 cases with analysis of factors predicting recurrence. Pai RK; Beck AH; Norton JA; Longacre TA Am J Surg Pathol; 2009 Oct; 33(10):1425-39. PubMed ID: 19641451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]